eLife is an open-access journal and technology provider that publishes promising research in the life and biomedical sciences. This is their implementation of a submission and peer review system based on Coko PubSweet and xPub.
@hdrury1 We've made a change to the author guide recently so Reviewer will need to be updated to match. Please replace the current "Preregistration" section of the Journal Policies page with the following:
Preregistration, Registered Reports, and Replication Studies
Preregistration of studies involves registering the study design, variables, and treatment conditions prior to conducting the research. For clinical trials, eLife follows the recommendations of the ICMJE that all trials must be prospectively registered to be considered for publication, and the clinical trial registration number will be requested during submission. For other submissions, authors are encouraged to consider whether preregistration would be appropriate, noting if they have done so within their cover letter and submission. If the preregistration included a precise analysis plan, that should be included as well.
We will consider Replication Studies that provide new insights into previously published research. We will apply the same editorial standards that we apply to other types of submission. We have also published Replication Studies (and Registered Reports) as part of the Reproducibility Project: Cancer Biology.
@hdrury1 We've made a change to the author guide recently so Reviewer will need to be updated to match. Please replace the current "Preregistration" section of the Journal Policies page with the following:
Preregistration, Registered Reports, and Replication Studies
Preregistration of studies involves registering the study design, variables, and treatment conditions prior to conducting the research. For clinical trials, eLife follows the recommendations of the ICMJE that all trials must be prospectively registered to be considered for publication, and the clinical trial registration number will be requested during submission. For other submissions, authors are encouraged to consider whether preregistration would be appropriate, noting if they have done so within their cover letter and submission. If the preregistration included a precise analysis plan, that should be included as well.
We will consider Replication Studies that provide new insights into previously published research. We will apply the same editorial standards that we apply to other types of submission. We have also published Replication Studies (and Registered Reports) as part of the Reproducibility Project: Cancer Biology.